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Cycling total parenteral nutrition (TPN) limits hepatic dysfunction in adults and children with intestinal
failure. Due to immature glucose homeostasis, this method is infrequently utilized in the neonatal
population.
Herein, we describe a successful case of cycled TPN in a neonate with complicated gastroschisis and
short bowel syndrome. Within three weeks the patient had a normalized direct bilirubin and did not
require pharmacologic intervention. There were two episodes of asymptomatic hypoglycemia associated
with intestinal obstruction.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cycling total parenteral nutrition (TPN) limits hepatic dysfunc-
tion and facilitates improved quality of life in adults and children
with intestinal failure [1]. Over time, this has been employed in
pediatric patients with functional and anatomical short gut syn-
drome. However, the application of cycled TPN has been infre-
quently utilized in neonates due to the concern for severe
hypoglycemia [2]. Here we discuss a successful case of cycled TPN
in a neonate with short bowel syndrome secondary to complicated
gastroschisis.1.1. Case report
Patient is a Caucasian male with prenatally diagnosed gastro-
schisis born at 36 weeks gestation to a G2P1 mother. At the time of
the delivery he was taken to the operating room for surgical closure
and found to have both a dilated duodenum and proximal jejunum,
and a small unused distal transverse colon. No other intestinal
anomaly was identiﬁed during the initial operation. Due to the
concern for complicated gastroschisis with suspected atresia, thes City, MO 64108, USA.
rickson).
Inc. This is an open access article upatient was transferred to a tertiary children's hospital for further
care.
The patient was maintained with gastric decompression and
parenteral nutrition with the plan to surgically intervene at
approximately 6 weeks of age. However, just prior to 4 weeks of
age, he developed increasing liver dysfunction demonstrated by a
direct hyperbilirubinemia and his TPN was transitioned to a cycling
regimen. Due to signs of developing TPN cholestasis, the patient
was taken back to the operating room2weeks early for exploration.
The suspected distal duodenal atresia was conﬁrmed. The bulbous
and dilated atretic end was resected, and the remaining few cen-
timeters of distal dilated duodenum were tapered and anasto-
mosed to 47 cm of jejunum and ileum (these additional 47 cmwere
identiﬁed during this laparotomy and not appreciated at the orig-
inal operation). Two additional atretic segments were identiﬁed
downstream, resected and anastomosed together, ending in a
functional ostomy. Total small intestine length was 60 cm from the
Ligament of Treitz to the ostomy incorporating three hand sewn
anastomoses. The right colon, hepatic ﬂexure and proximal trans-
verse colon were atretic and removed. A very small caliber mid-
transverse colon was identiﬁed and brought out as a mucous ﬁs-
tula for eventual rehabilitation. Postoperatively the patient failed to
have return of bowel function via the end ileostomy and was
diagnosed by contrast imaging with a stricture at the most distal
anastomosis, located 4 cm proximal to the stoma. Rehabilitation ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ogram(kg) of normal saline as an antegrade enema via the mucous
ﬁstula two times per day. Sevenweeks later he underwent stricture
resection, stoma takedown and reanastomosis. Although the pa-
tient stooled initially, he developed bilious emesis and was taken
back to the operating room for a third time. The patient's most
proximal anastomosis had obstructed and was revised in a
Heineke-Mikulicz fashion.
Cycled TPN was maintained from the original signs of liver
dysfunction throughout the patient's complicated course. Ulti-
mately the patient was weaned off TPN 35 days following his
third operation. At that time he had advanced to goal volume
enteral feeds. Over the next three weeks, the patient had forti-
ﬁcation of his enteral feeds to ensure adequate weight gain. He
also had soluble ﬁber and sodium supplementation to counteract
the ﬂuid and electrolyte loss due to decreased small intestine
length.
Within the ﬁrst 48 h of life, the patient was placed on fat
emulsion 20% at 1 g(g)/kg/day(d) and increased up to 3 g/kg/d.
Following the development of direct hyperbilirubinemia, his lipid
delivery was restricted to 1 g/kg/d where it remained for the
duration of TPN. The glucose infusion rate ranged from 12.15 to
16.15 mg(mg)/kg/minute(min) when on continuous TPN based on
the patient's caloric growth needs of 90e105 kilocalories/kg/d.
While on cycled TPN the glucose infusion rate was 16.7e19.0 mg/
kg/min. The amino acid (Premasol) component was 4 g/kg/d in or-
der to assist postoperative healing.
The patient received parenteral nutrition 22 h of the day.
Intravenous ﬂuids were infused at 2 ml/h for the remaining 2 h to
maintain central line patency. Initially the patient was placed on
half normal saline with 0.5 unit heparin during that time, however
due to hyponatremia, this was transitioned to normal saline with
0.5 unit heparin.
The rate of TPN infusion was tapered in order to prevent a
sudden decrease in the patient's glycemic status. At 4 p.m. daily, the
TPN was initiated at ¼ goal rate and increased to ½ goal rate 1 h
later. From 6 p.m. to 12 p.m. the following day, the TPN was infused
at goal rate. From 12 to 1 p.m. it was then decreased to ½ goal rate
again, and then decreased to¼ goal rate the following hour. From 2
to 4 pm the TPN was discontinued (Fig. 1). Rates were calculated
based on the total volume of the daily TPN created.
The electrolytes were closely monitored and adjusted accord-
ingly. A basic metabolic proﬁle, liver function tests, magnesium andFig. 1. Cycled TPN regimen.phosphorus levels were obtained at the minimum biweekly. If
signiﬁcant adjustments were made, additional laboratory values
were obtained. The most signiﬁcant perturbation was the chlor-
ide:acetate balance. While clinically obstructed, the patient's high
gastric output required elevated chloride concentrations (up to 11
mEq(milliequivalents)/kg/d) with minimal acetate to counteract
electrolyte loss. The sodium concentration was also increased (10
mEq/kg/d). With the return of bowel function following surgery,
resultant decrease in gastric output, and initiation of enteral feeds,
these concentrations were decreased to normal range. Chloride to
acetate ratio was then maintained at 2:1.
The patient's weight ﬂuctuated as expected during periopera-
tive periods. However, he demonstrated consistent growth
remaining just under the 3rd percentile (Fig. 2).
The patient only had two episodes of hypoglycemia (glucose
level <50 mg/dL). These episodes were during acute illness sec-
ondary to a proximal intestinal obstruction. The patient was clini-
cally asymptomatic at the time of phlebotomy.
Following the transition to cycled TPN, the patient's direct bili-
rubin began to decrease and returned to normal limits. His direct
bilirubin improved from 3.4 mg/(deciliter)dL to 0.1 mg/dL prior to
discharge. The direct hyperbilirubinemia had decreased below
1.0 mg/dL within 3 weeks (Fig. 3). He did not require medical
therapy with ursodiol or phenobarbital.2. Discussion
Parenteral nutrition-associated liver disease ranges from tem-
poral cholestasis to cirrhosis and even mortality. Cycling TPN has
been implemented as one method to minimize liver damage in
these patients [3]. The temporary cessation of amino acids and
dextrose infusion has been theorized to improve substrate utiliza-
tion and decrease lipogenesis within the liver [2,3].
Although prior data is limited, case reports similar to above,
have prompted not only cyclic TPN as a therapeutic measure but
also as prophylaxis. One retrospective review of prophylactic cycled
TPN versus continuous TPN in gastroschisis patients found time to
direct hyperbilirubinemia was signiﬁcantly longer [4]. A separate
review in surgical neonates comparing prophylactic cycled TPN
versus therapeutic cycled TPN also found a signiﬁcantly lower
incidence of elevated direct bilirubin. Of note, these patients did not
demonstrate an increase in hypoglycemia or hypertriglyceridemia
[2].
In complicated gastroschisis, TPN is the only source of nutrition
and may be required for extended periods of time. Moreover, in
complicated gastroschisis with short bowel syndrome, long term
TPN will need to be utilized to maximize caloric requirements. This
is paramount as a longer TPN course and elevated dextrose in-
fusions are independent risk factors for TPN cholestasis [5]. Given
the inherent dysmotility which occurs in gastroschisis, only com-
pounded by short bowel syndrome, we sought to maximize caloric
intake while trying to minimize the toxicity of TPN. We opted to
cycle TPN in hopes of minimizing or even reversing the hepato-
toxicity while the intestine was allowed to heal from operative
interventions. As demonstrated by the return of direct bilirubin to
normal range and continued growth, this strategy was not only
effective in protecting the liver but was also safely performed in this
neonate. Of note, the rehabilitation of the distal intestine via the
mucous ﬁstula also appeared to allow better post-operative intes-
tinal function, and thus, shorter time to full enteral nutrition.
Despite these early successes, cycled TPN has not experienced
widespread acceptance. Further research, particularly in neonates,
will provide the basis for future implementation.
Fig. 2. Growth chart.
Fig. 3. Direct hyperbilirubinemia.
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This case demonstrates the safe and therapeutic implementa-
tion of cycled TPN in a surgical neonate, limiting hepatic dysfunc-
tion due to prolonged parenteral nutrition.
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